Related Experiment Video

Updated: Aug 25, 2026

Heterokaryon Technique for Analysis of Cell Type-specific Localization
09:31

Heterokaryon Technique for Analysis of Cell Type-specific Localization

Published on: March 11, 2011

The tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virus

Cristina Oro1, David A Jans

  • 1Nuclear Signaling Laboratory, Dept. for Biochemistry and Mol. Biol., PO Box 13D, Monash University 3800, Australia.

Current Drug Targets
|March 12, 2004
PubMed

Insights

Apoptin, a viral protein, shows promise as a novel anti-cancer treatment. It specifically targets tumor cells to induce apoptosis, offering a potential solution for drug-resistant cancers.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
  • Despite advances in understanding tumorigenesis, developing specific and efficient anti-cancer treatments is still difficult.
  • Existing treatments often lack specificity and struggle with drug-resistant cancer cells.

Purpose of the Study:

  • To review the unique properties of Apoptin (viral protein 3 - VP3) as a potential anti-cancer agent.
  • To explore Apoptin's tumor-specific, p53-independent, and Bcl-2-enhanced pro-apoptotic activity.
  • To examine the mechanism of Apoptin's selective nuclear localization in transformed cells.

Main Methods:

  • Literature review of studies on Apoptin's biological activity.
  • Analysis of Apoptin's molecular interactions and cellular localization.
  • Examination of Apoptin's efficacy in preclinical cancer models.

Main Results:

  • Apoptin exhibits potent pro-apoptotic activity specifically in tumor cells, independent of p53.
  • Its efficacy is enhanced in the presence of Bcl-2, a common factor in drug resistance.
  • Apoptin selectively accumulates in the nucleus of cancer cells but not normal cells.

Conclusions:

  • Apoptin represents a novel therapeutic candidate for cancer treatment due to its tumor-specific pro-apoptotic action.
  • Its ability to target cancer cells selectively, even those resistant to conventional therapies, highlights its potential.
  • Further research into Apoptin's mechanisms could lead to more effective and targeted cancer therapies.

More Related Videos

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Examination of Pyroptosis by Flow Cytometry05:14

Examination of Pyroptosis by Flow Cytometry

Published on: May 31, 2024

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...